Novelion Therapeutics Inc. buy melinda
Start price
14.10.18
/
50%
?0.95
Target price
07.11.18
€1.80
Performance (%)
-32.36%
End price
07.11.18
€0.64
Summary
This prediction ended on 07.11.18 with a price of €0.64. Massive losses of -32.36% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novelion Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0.786% | -0.427% | 17.458% | 17.620% |
| iShares Nasdaq 100 | 2.297% | 7.331% | 38.189% | 53.439% |
| iShares Nikkei 225® | 3.076% | 3.279% | 13.174% | 10.191% |
| iShares S&P 500 | 0.902% | 3.970% | 29.787% | 46.282% |
Comments by melinda for this prediction
In the thread Novelion Therapeutics Inc. diskutieren
SecteurRecherche biotechnologique et médicale Agenda 08/11 Publication de résultats
Novelion Therapeutics, Inc. engages in the development and commercialization of pharmaceuitical products.
It focuses in providing new standards of care for individuals living with rare diseases.
The company is headquartered in Vancouver, Canada.
Nombre d'employés : 180 personnes.
(Vom Mitglied beendet)
Stopped prediction by melinda for Novelion Therapeutics Inc.
Novelion Therapeutics Inc.
Start price
Target price
Perf. (%)
?0.83
27.05.19
27.05.19
€1.17
15.11.19
15.11.19
0.00%
15.11.19
15.11.19
Novelion Therapeutics Inc.
Start price
Target price
Perf. (%)
?4.39
06.11.17
06.11.17
€6.31
06.12.17
06.12.17
-31.21%
06.12.17
06.12.17
Novelion Therapeutics Inc.
Start price
Target price
Perf. (%)
?8.40
13.05.17
13.05.17
€9.92
22.06.17
22.06.17
5.32%
22.06.17
22.06.17
Novelion Therapeutics Inc.
Start price
Target price
Perf. (%)
?18.89
06.12.13
06.12.13
€17.14
06.06.14
06.06.14
0.00%
06.06.14
06.06.14